Medicare Enrolled
Dr. David Schnapp, MD
Urology Physician · Auburn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schnapp from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schnapp?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schnapp
Dr. David Schnapp is an urology physician in Auburn, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Schnapp performed 5,550 Medicare services across 3,086 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schnapp received a total of $6,266 from 43 pharmaceutical and/or device companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schnapp is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in NY
$6,266 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,550
Medicare services
Top 16% in NY for urology physician
3,086
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~292 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,368 | $2 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
718 | $62 | $180 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
717 | $8 | $11 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
612 | $88 | $265 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
428 | $7 | $46 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
231 | $48 | $124 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
204 | $22 | $130 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
150 | $178 | $730 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
143 | $47 | $123 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 120 | $135 | $1,500 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
93 | $45 | $153 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
93 | $54 | $184 |
| Injection, garamycin, gentamicin, up to 80 mg | 87 | $2 | $10 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
73 | $676 | $2,295 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
70 | $103 | $405 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
55 | $33 | $94 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $101 | $400 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
42 | $42 | $138 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
35 | $183 | $960 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $40 | $105 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $11 | $62 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
28 | $24 | $345 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
24 | $149 | $395 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
23 | $26 | $79 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
22 | $284 | $767 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $63 | $265 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
21 | $9 | $96 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
18 | $990 | $3,005 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $18 | $50 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
13 | $64 | $334 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
12 | $2,243 | $8,445 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,266
Total received (2018-2024)
Avg $895/year across 7 years
Top 26% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
188
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,734 (59.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,400 (38.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$131 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$776
2023
$1,042
2022
$704
2021
$824
2020
$144
2019
$345
2018
$2,429
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$161
Myriad Genetic Laboratories, Inc.
$125
ABBVIE INC.
$123
Ferring Pharmaceuticals Inc.
$80
Sumitomo Pharma America, Inc.
$78
ACCORD HEALTHCARE, INC.
$51
Teleflex LLC
$49
Olympus America Inc.
$46
Janssen Biotech, Inc.
$34
UROGEN PHARMA, INC.
$30
Top 3 companies account for 52.6% of 2024 payments
All-time payments by company (2018-2024) ›
NxThera, Inc.
$2,400
Myriad Genetic Laboratories, Inc.
$406
Dendreon Pharmaceuticals LLC
$356
Janssen Biotech, Inc.
$335
Astellas Pharma US Inc
$322
Teleflex LLC
$288
ACCORD HEALTHCARE, INC.
$157
Sumitomo Pharma America, Inc.
$156
NeoTract Inc.
$155
AbbVie Inc.
$133
ABBVIE INC.
$123
UROVANT SCIENCES INC
$122
PFIZER INC.
$96
Olympus America Inc.
$84
Ferring Pharmaceuticals Inc.
$80
UROGEN PHARMA, INC.
$73
Merck Sharp & Dohme LLC
$72
Bayer HealthCare Pharmaceuticals Inc.
$71
Bayer Healthcare Pharmaceuticals Inc.
$63
Endo Pharmaceuticals Inc.
$57
Medtronic, Inc.
$57
Blue Earth Diagnostics Limited
$53
Axonics, Inc.
$51
PROCEPT BioRobotics Corporation
$51
BOSTON SCIENTIFIC CORPORATION
$44
Otsuka America Pharmaceutical, Inc.
$44
Boston Scientific Corporation
$40
Myovant Sciences Inc.
$40
Clarus Therapeutics Inc.
$36
Allergan, Inc.
$36
Antares Pharma, Inc.
$34
UroGen Pharma, Inc.
$27
TOLMAR Pharmaceuticals, Inc.
$24
Amgen Inc.
$23
Supernus Pharmaceuticals, Inc.
$21
ROCHESTER MEDICAL CORPORATION
$19
PALETTE LIFE SCIENCES, INC.
$18
Medtronic USA, Inc.
$17
Coloplast Corp
$17
COLOPLAST CORP
$17
TherapeuticsMD, Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
Cook Medical LLC
$14
Top 3 companies account for 50.5% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · AQUABEAM ROBOTIC SYSTEM · Axonics · Axumin · BOTOX · Bulkamid · CAMCEVI · Cook Medical Stents · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · General - BPH · IMVEXXY · INTERSTIM · JATENZO · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · OTREXUP · PROLARIS · PROVENGE · REZUM · ReTrace · Rezum · TLANDO · UROLIFT · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
56
Per 100K population
74.2
County median income
$66,583
Nearest hospital
AUBURN COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Schnapp is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NY), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Schnapp experienced with automated urinalysis?
Based on Medicare claims data, Dr. Schnapp performed 1,368 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schnapp receive payments from pharmaceutical companies?
Yes. Dr. Schnapp received a total of $6,266 from 43 companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schnapp's costs compare to other urology physicians in Auburn?
Dr. Schnapp's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schnapp) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Auburn
Browse urology physicians in Auburn ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
NxThera, Inc. Payments to Doctors
See all physicians who received payments from NxThera, Inc.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology